Deutsche Bank’s Scinai Immunotherapeutics SCNI Stock Holding History

Deutsche Bank’s Portfolio SCNI Stock Details SCNI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Hold	0	–	-$13K	–	4511
2020 Q3	–	Hold	0	–	–	–	4168
2020 Q1	–	Hold	0	–	-$1K	–	4759
2019 Q4	–	Sell	-1	Closed	-$6.14K	–	4927
2019 Q3	$2K	Buy	+1	New	+$5.91K	﹤0.01%	4779
2019 Q2	–	Hold	0	–	–	–	5485
2019 Q1	–	Hold	0	–	–	–	5399
2018 Q4	–	Sell	-3	Closed	-$15K	–	5381
2018 Q3	$15K	Sell	3 -4	-57%	-$23.9K	﹤0.01%	5004
2018 Q2	$44K	Sell	7 -3	-30%	-$19.4K	﹤0.01%	4823
2018 Q1	$55K	Sell	10 -26	-72%	-$162K	﹤0.01%	4725
2017 Q4	$192K	Buy	36 +9	+33%	+$56.6K	﹤0.01%	4049
2017 Q3	$192K	Buy	27 +26	+2,600%	+$213K	﹤0.01%	3904
2017 Q2	$5K	Hold	1	–	–	﹤0.01%	4753
2017 Q1	$5K	Buy	+1	New	+$5.15K	﹤0.01%	4708

Other funds holding SCNI

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $6.54B AUM

Deutsche Bank's SCNI Position: Q4 2020 in Review

Deutsche Bank held its Scinai Immunotherapeutics (SCNI) position steady in Q4 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4511.

Deutsche Bank first reported a position in SCNI in Q1 2017 and has held it in 8 quarters since. The position peaked at $192K in Q4 2017. 10 funds tracked by Wall St. Rank hold SCNI as of Q4 2020.

Deutsche Bank held 0 shares of Scinai Immunotherapeutics worth $0 as of Q4 2020.
Deutsche Bank left its Scinai Immunotherapeutics share count unchanged in Q4 2020.
Scinai Immunotherapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q4 2020, its #4511 holding.
Deutsche Bank first reported a position in Scinai Immunotherapeutics in Q1 2017 and has held it in 8 quarters since.
Deutsche Bank's Scinai Immunotherapeutics position peaked at $192K in Q4 2017.
10 funds tracked by Wall St. Rank held Scinai Immunotherapeutics as of Q4 2020.

Based on Deutsche Bank's 13F filing for Q4 2020, filed 16 Feb 2021.